Abstract
Prostate cancer is one of the most prevalent malignancies affecting men worldwide. Despite advancements in understanding prostate anatomy and minimally invasive approaches to surgical treatment, surgery can have significant adverse effects on sexual function. Penile rehabilitation strategies have emerged as a promising approach to mitigate the impact of prostate cancer treatments on erectile function and improve quality of life. Several methods have been employed for penile rehabilitation, including pharmacotherapy, vacuum erection devices, intracavernous injections, and emerging novel techniques. Yet, there is no consensus on the exact programs or timing of initiation that should be utilized for optimal recovery after surgery. This review discusses various rehabilitation protocols and long-term outcomes and explores the cost-effectiveness of different interventions. Additionally, this review discusses the importance of a multidisciplinary approach to penile rehabilitation which includes patient education, counseling, and the selection of an appropriate rehabilitation strategy tailored to each individual’s needs and preferences. Continued research and collaboration among healthcare professionals are essential to refine rehabilitation approaches and ensure optimal outcomes for patients with prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Culp MB, Soerjomataram I, Efstathiou JA, Bray F, Jemal A. Recent global patterns in prostate cancer incidence and mortality rates. Eur Urol. 2020;77:38–52. https://www.sciencedirect.com/science/article/pii/S0302283819306190.
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA Cancer J Clin. 2022;72:7–33.
EAU Guidelines. Edn. presented at the EAU Annual Congress Milan 2023. ISBN 978-94-92671-19-6.
Walsh PC, Lepor H, Eggleston JC. Radical prostatectomy with preservation of sexual function: anatomical and pathological considerations. Prostate. 1983;4:473–85. https://doi.org/10.1002/pros.2990040506.
Mulhall JP. Defining and reporting erectile function outcomes after radical prostatectomy: challenges and misconceptions. J Urol. 2009;181:462–71.
Ficarra V, Novara G, Rosen RC, Artibani W, Carroll PR, Costello A, et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur Urol. 2012;62:405–17.
Ramsey SD, Zeliadt SB, Blough DK, Moinpour CM, Hall IJ, Smith JL, et al. Impact of prostate cancer on sexual relationships: a longitudinal perspective on intimate partners’ experiences. J Sex Med. 2013;10:3135–43. https://doi.org/10.1111/jsm.12295.
Latini DM, Penson DF, Wallace KL, Lubeck DP, Lue TF. Clinical and psychosocial characteristics of men with erectile dysfunction: baseline data from ExCEEDTM. J Sex Med. 2006;3:1059–67. https://doi.org/10.1111/j.1743-6109.2006.00331.x.
Capogrosso P, Pozzi EP, Celentano V, Sanchez-Salas R, Salonia A. Erectile recovery after radical pelvic surgery: methodological challenges and recommendations for data reporting. J Sex Med. 2020;17:7–16. https://doi.org/10.1016/j.jsxm.2019.09.013.
Neijenhuijs KI, Holtmaat K, Aaronson NK, Holzner B, Terwee CB, Cuijpers P, et al. The International Index of Erectile Function (IIEF)—a systematic review of measurement properties. J Sex Med. 2019;16:1078–91. https://doi.org/10.1016/j.jsxm.2019.04.010.
Terrier JE, Mulhall JP, Nelson CJ. Exploring the optimal erectile function domain score cutoff that defines sexual satisfaction after radical prostatectomy. J Sex Med. 2017;14:804–9. https://doi.org/10.1016/j.jsxm.2017.04.672.
Briganti A, Gallina A, Suardi N, Capitanio U, Tutolo M, Bianchi M, et al. What is the definition of a satisfactory erectile function after bilateral nerve sparing radical prostatectomy? J Sex Med. 2011;8:1210–7. https://doi.org/10.1111/j.1743-6109.2010.02179.x.
Mulhall JP, Brock G, Oelke M, Fode M, Probst KA, Henneges C, et al. Effects of tadalafil once-daily or on-demand vs placebo on return to baseline erectile function after bilateral nerve-sparing radical prostatectomy—results from a randomized controlled trial (REACTT). J Sex Med. 2016;13:679–83. https://doi.org/10.1016/j.jsxm.2016.01.022.
Schwartz EJ, Wong P, Graydon RJ. Sildenafil preserves intracorporeal smooth muscle after radical retropubic prostatectomy. J Urol. 2004;171:771–4. https://doi.org/10.1097/01.ju.0000106970.97082.61.
Montorsi F, Brock G, Stolzenburg J-U, Mulhall J, Moncada I, Patel HRH, et al. Effects of tadalafil treatment on erectile function recovery following bilateral nerve-sparing radical prostatectomy: a randomised placebo-controlled study (REACTT). Eur Urol. 2014;65:587–96. https://www.sciencedirect.com/science/article/pii/S0302283813010543.
Jo JK, Jeong SJ, Oh JJ, Lee SW, Lee S, Hong SK, et al. Effect of starting penile rehabilitation with sildenafil immediately after robot-assisted laparoscopic radical prostatectomy on erectile function recovery: a prospective randomized trial. J Urol. 2018;199:1600–6. https://www.sciencedirect.com/science/article/pii/S0022534718300090.
Kim S, Sung GT. Efficacy and safety of tadalafil 5 mg once daily for the treatment of erectile dysfunction after robot-assisted laparoscopic radical prostatectomy: a 2-year follow-up. Sex Med. 2018;6:108–14. https://doi.org/10.1016/j.esxm.2017.12.005.
Miranda EP, Benfante N, Kunzel B, Nelson CJ, Mulhall JP. A randomized, controlled, 3-arm trial of pharmacological penile rehabilitation in the preservation of erectile function after radical prostatectomy. J Sex Med. 2021;18:423–9. https://doi.org/10.1016/j.jsxm.2020.10.022.
Reza SM, Mohammad A, Lin Y, Keiichiro M, Benjamin P, Ekaterina L, et al. Penile rehabilitation strategy after nerve sparing radical prostatectomy: a systematic review and network meta-analysis of randomized trials. J Urol. 2021;205:1018–30. https://doi.org/10.1097/JU.0000000000001584.
Montorsi F, Guazzoni G, Strambi LF, Da Pozzo LF, Nava L, Barbieri L, et al. Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: results of a prospective, randomized trial. J Urol. 1997;158:1408–10.
Polito M, d’Anzeo G, Conti A, Muzzonigro G. Erectile rehabilitation with intracavernous alprostadil after radical prostatectomy: refusal and dropout rates. BJU Int. 2012;110:E954–7.
Teloken P, Mesquita G, Montorsi F, Mulhall J. Post-radical prostatectomy pharmacological penile rehabilitation: practice patterns among the international society for sexual medicine practitioners. J Sex Med. 2009;6:2032–8. https://doi.org/10.1111/j.1743-6109.2009.01269.x.
Feng D, Liu S, Yang Y, Bai Y, Li D, Han P, et al. Generating comprehensive comparative evidence on various interventions for penile rehabilitation in patients with erectile dysfunction after radical prostatectomy: a systematic review and network meta-analysis. Transl Androl Urol. 2021;10:109–24.
Pirola GM, Naselli A, Maggi M, Gubbiotti M, Rubilotta E, Jeremy Yuen‑Chun T, et al. Vacuum erection device for erectile function rehabilitation after radical prostatectomy: which is the correct schedule? Results from a systematic, scoping review. Int J Impot Res. 2023. https://doi.org/10.1038/s41443-023-00700-w.
Clavijo RI, Kohn TP, Kohn JR, Ramasamy R. Effects of low-intensity extracorporeal shockwave therapy on erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2017;14:27–35. https://doi.org/10.1016/j.jsxm.2016.11.001.
Baccaglini W, Pazeto CL, Corrêa Barros EA, Timóteo F, Monteiro L, Saad Rached RY, et al. The role of the low-intensity extracorporeal shockwave therapy on penile rehabilitation after radical prostatectomy: a randomized clinical trial. J Sex Med. 2020;17:688–94. https://doi.org/10.1016/j.jsxm.2019.12.024.
Rosen RC, Allen KR, Ni X, Araujo AB. Minimal clinically important differences in the erectile function domain of the international index of erectile function scale. Eur Urol. 2011;60:1010–6. https://www.sciencedirect.com/science/article/pii/S0302283811007913.
Briganti A, Montorsi F. Penile rehabilitation after radical prostatectomy. Nat Clin Pract Urol. 2006;3:400–1.
Müller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K, Paduch D, et al. The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model. J Sex Med. 2008;5:562–70. https://doi.org/10.1111/j.1743-6109.2007.00727.x.
Chiles KA, Staff I, Johnson-Arbor K, Champagne A, McLaughlin T, Graydon RJ. A double-blind, randomized trial on the efficacy and safety of hyperbaric oxygenation therapy in the preservation of erectile function after radical prostatectomy. J Urol. 2018;199:805–11. https://www.sciencedirect.com/science/article/pii/S0022534717777208.
Yiou R, Hamidou L, Birebent B, Bitari D, Le Corvoisier P, Contremoulins I, et al. Intracavernous injections of bone marrow mononucleated cells for postradical prostatectomy erectile dysfunction: final results of the INSTIN clinical trial. Eur Urol Focus. 2017;3:643–5. https://www.sciencedirect.com/science/article/pii/S2405456917301608.
Saltzman RG, Golan R, Masterson TA, Sathe A, Ramasamy R. Restorative therapy clinical trials for erectile dysfunction: a scoping review of endpoint measures. Int J Impot Res. 2022. https://doi.org/10.1038/s41443-022-00610-3.
Albaugh J, Adamic B, Chang C, Kirwen N, Aizen J. Adherence and barriers to penile rehabilitation over 2 years following radical prostatectomy. BMC Urol. 2019;19:89. https://doi.org/10.1186/s12894-019-0516-y.
Mishra K, Bukavina L, Mahran A, Bobrow A, Buzzy CA, Jain N. et al. Variability in prices for erectile dysfunction medications—are all pharmacies the same?. J Sex Med. 2018;15:1785–91. https://doi.org/10.1016/j.jsxm.2018.10.011.
Schneider D, Loeb CA, Brevik A, el-Khatib F, Jenkins LC, Yafi FA. Contemporary cost-analysis comparison of direct-to-consumer vs. traditional prescriptions of phosphodiesterase-5 inhibitors. Int J Impot Res. 2023;35:460–4. https://doi.org/10.1038/s41443-022-00567-3.
Siena G, Mari A, Canale A, Mondaini N, Chindemi A, Greco I, et al. Sexual rehabilitation after nerve-sparing radical prostatectomy: free-of-charge phosphodiesterase type 5 inhibitor administration improves compliance to treatment. J Sex Med. 2018;15:120–3. https://doi.org/10.1016/j.jsxm.2017.12.011.
Nelson CJ, Saracino RM, Napolitano S, Pessin H, Narus JB, Mulhall JP. Acceptance and commitment therapy to increase adherence to penile injection therapy-based rehabilitation after radical prostatectomy: pilot randomized controlled trial. J Sex Med. 2019;16:1398–408. https://doi.org/10.1016/j.jsxm.2019.05.013.
Mulhall JP, Kattan MW, Bennett NE, Stasi J, Nascimento B, Eastham J, et al. Development of nomograms to predict the recovery of erectile function following radical prostatectomy. J Sex Med. 2019;16:1796–802. https://doi.org/10.1016/j.jsxm.2019.08.003.
Osadchiy V, Eleswarapu SV, Mills SA, Pollard ME, Reiter RE, Mills JN. Efficacy of a preprostatectomy multi-modal penile rehabilitation regimen on recovery of postoperative erectile function. Int J Impot Res. 2020;32:323–8. https://doi.org/10.1038/s41443-019-0187-y.
Li R, Wittmann D, Nelson CJ, Salter CA, Mulhall JP, Byrne N, et al. Unmet sexual health needs of patients and female partners following diagnosis and treatment for prostate cancer. J Sex Med. 2022;19:1797–803. https://doi.org/10.1016/j.jsxm.2022.08.195.
Gupta N, Zebib L, Wittmann D, Nelson CJ, Salter CA, Mulhall JP, et al. Understanding the sexual health perceptions, concerns, and needs of female partners of prostate cancer survivors. J Sex Med. 2023;20:651–60. https://doi.org/10.1093/jsxmed/qdad027.
Loeb S, Salter CA, Nelson CJ, Mulhall JP, Wittmann D. A call to arms: increasing our understanding of the impact of prostate cancer on the sexual health of partners. J Sex Med. 2020;17:361–3. https://doi.org/10.1016/j.jsxm.2019.11.262.
Author information
Authors and Affiliations
Contributions
MB: acquired data and designed the paper, drafted manuscript, approved final version. RTB: helped draft several sections of the manuscript, prepared edits and revised manuscript, wrote final version. TP: helped draft several sections of the manuscript, prepared edits and revised manuscript, wrote final version. HB: designed manuscript and conceived idea for work, revised manuscript, approved final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bock, M., Burns, R.T., Pereira, T.A. et al. A contemporary review of the treatments and challenges associated with penile rehabilitation after radical prostatectomy including a proposed optimal approach. Int J Impot Res (2023). https://doi.org/10.1038/s41443-023-00782-6
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41443-023-00782-6